secwatch.observer — SEC 8-K summary
======================================

Issuer:     Context Therapeutics Inc. (CNTX)
CIK:        0001842952
Form:       8-K
Filed at:   2022-01-10T23:59:59+00:00
Accession:  0001842952-22-000009
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Context Therapeutics updates corporate presentation, no new figures disclosed
-----------------------------------------------------------------------------

- Filed an updated corporate presentation dated January 2022 under Item 8.01.
- Presentation titled 'Bringing Change for Female Cancers' but contains no disclosed financial or pipeline specifics.
- No material operational or financial updates beyond the filing itself.
- Ticker: CNTX; stock trades on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842952/000184295222000009/0001842952-22-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842952/000184295222000009/cntx-20220110.htm
  HTML page:      https://secwatch.observer/filing/0001842952-22-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer